Current Evidence on the Ocular Surface Microbiota and Related Diseases.

microbiota ocular surface ophthalmic diseases

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
13 Jul 2020
Historique:
received: 15 06 2020
revised: 04 07 2020
accepted: 10 07 2020
entrez: 17 7 2020
pubmed: 17 7 2020
medline: 17 7 2020
Statut: epublish

Résumé

The ocular surface microbiota refers to the resident non-pathogenic microorganisms that colonize conjunctiva and cornea. Several studies have shown that ocular surface epithelial cells can respond selectively to specific components of ocular pathogenic bacteria by producing pro-inflammatory cytokines and, in contrast, they do not respond to non-pathogenic bacteria, thus supporting the colonization by a real microbiota. However, the analysis of the ocular microbiome composition is essential for understanding the pathophysiology of various ophthalmic diseases. In this scenario, the first studies, which used microbiological culture techniques, reported a less diverse profile of the ocular microbiota compared with that recently discovered using new molecular-based methods. Indeed, until a few years ago, the microbiota of the ocular surface appeared to be dominated by Gram-positive and a few Gram-negative bacteria, as well as some fungal strains. In contrast, genomics has nowadays detected a remarkable diversity in the ocular surface microorganisms. Furthermore, recent studies suggest that the microbiota of other areas of the body, such as the gut and oral microbiota, are involved in the pathophysiology of several ophthalmic diseases. The aim of the present study is to highlight the current evidence on the ocular surface microbiota to better understand it and to investigate its potential role in the development of ophthalmic diseases.

Identifiants

pubmed: 32668575
pii: microorganisms8071033
doi: 10.3390/microorganisms8071033
pmc: PMC7409318
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Clin Ophthalmol. 2018 Jul 02;12:1189-1197
pubmed: 30013312
Front Immunol. 2018 Jan 25;9:52
pubmed: 29422899
Nature. 2012 Oct 4;490(7418):55-60
pubmed: 23023125
Exp Eye Res. 2013 Dec;117:53-61
pubmed: 23880529
Yale J Biol Med. 2016 Sep 30;89(3):325-330
pubmed: 27698616
Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5616-23
pubmed: 18055811
Int Rev Immunol. 2013 Feb;32(1):1-3
pubmed: 23360154
Korean J Ophthalmol. 1989 Jun;3(1):38-41
pubmed: 2795940
J Immunol. 2004 Sep 1;173(5):3337-47
pubmed: 15322197
Ophthalmology. 2013 May;120(5):937-41
pubmed: 23415422
Curr Eye Res. 2018 Mar;43(3):314-324
pubmed: 29172724
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6030-6037
pubmed: 29196767
Invest Ophthalmol Vis Sci. 2017 Sep 1;58(11):4593-4600
pubmed: 28892827
Exp Eye Res. 2004 Mar;78(3):347-60
pubmed: 15106912
Curr Opin Ophthalmol. 2018 May;29(3):261-266
pubmed: 29538183
J Nutr. 2007 Mar;137(3 Suppl 2):830S-7S
pubmed: 17311983
Curr Mol Med. 2006 May;6(3):327-37
pubmed: 16712478
Ocul Immunol Inflamm. 2019;27(6):1023-1032
pubmed: 30096001
Genome Res. 2009 Jul;19(7):1141-52
pubmed: 19383763
Curr Eye Res. 2003 Jan;26(1):33-6
pubmed: 12789534
JAMA Ophthalmol. 2015 Dec;133(12):1445-54
pubmed: 26502312
Exp Eye Res. 2013 Dec;117:99-105
pubmed: 23797046
Nat Immunol. 2001 Aug;2(8):675-80
pubmed: 11477402
Curr Opin Ophthalmol. 2016 Nov;27(6):552-560
pubmed: 27585211
Curr Clin Pharmacol. 2017;12(2):99-105
pubmed: 28676009
Clin Microbiol Infect. 2016 Jul;22(7):643.e7-643.e12
pubmed: 27102141
Ocul Surf. 2016 Apr;14(2):255-63
pubmed: 26795265
Pediatrics. 1979 Mar;63(3):451-5
pubmed: 440845
Cornea. 2015 Sep;34(9):1130-6
pubmed: 26203745
PLoS One. 2014 Sep 02;9(9):e104416
pubmed: 25180891
Curr Opin Allergy Clin Immunol. 2009 Oct;9(5):466-70
pubmed: 19620859
Nature. 2015 Dec 10;528(7581):262-266
pubmed: 26633628
Invest Ophthalmol Vis Sci. 2011 Jul 20;52(8):5408-13
pubmed: 21571682
Clin Exp Optom. 2017 Sep;100(5):459-472
pubmed: 28771841
Optom Vis Sci. 2014 Jan;91(1):13-23
pubmed: 24240353
Adv Exp Med Biol. 1994;350:231-8
pubmed: 8030482
Clin Microbiol Infect. 2008 Oct;14(10):908-34
pubmed: 18828852
Nature. 2018 Oct;562(7728):589-594
pubmed: 30356183
Ophthalmology. 2001 Mar;108(3):470-8
pubmed: 11237900
Clin Ter. 2017 May-Jun;168(3):e181-e185
pubmed: 28612893
Brain Res Bull. 2010 Feb 15;81(2-3):219-28
pubmed: 19828129
Am J Clin Nutr. 2000 Jun;71(6 Suppl):1682S-7S; discussion 1688S-90S
pubmed: 10837317
Am J Ophthalmol. 2007 Nov;144(5):690-698
pubmed: 17727808
Front Microbiol. 2018 Nov 27;9:2899
pubmed: 30538693
Microbiol Rev. 1987 Jun;51(2):221-71
pubmed: 2439888
Lancet Infect Dis. 2016 Feb;16(2):239-51
pubmed: 26795692
Invest Ophthalmol Vis Sci. 2012 Aug 15;53(9):5585-93
pubmed: 22836761
Appl Environ Microbiol. 2004 Sep;70(9):5258-65
pubmed: 15345408
JAMA Ophthalmol. 2013 Apr;131(4):456-61
pubmed: 23430175
Sci Rep. 2018 Sep 3;8(1):13117
pubmed: 30177735
Genome Med. 2014 Nov 15;6(11):99
pubmed: 25484919
Klin Monbl Augenheilkd. 1994 Dec;205(6):348-57
pubmed: 7869685
Sci Rep. 2017 Aug 29;7(1):9880
pubmed: 28852195
Cornea. 2008 Sep;27 Suppl 1:S31-40
pubmed: 18813073
PLoS Pathog. 2016 Sep 22;12(9):e1005855
pubmed: 27658245
Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4472-E4481
pubmed: 28507131
Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):503-14
pubmed: 20664519
mBio. 2016 Mar 22;7(2):e00198
pubmed: 27006462
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):851-862
pubmed: 28229218
Nat Rev Microbiol. 2011 Nov 21;10(1):66-78
pubmed: 22101918
BMC Ophthalmol. 2013 Nov 15;13:71
pubmed: 24238071
Immunity. 2015 Aug 18;43(2):343-53
pubmed: 26287682
Invest Ophthalmol Vis Sci. 2001 May;42(6):1164-71
pubmed: 11328723
Clin Dermatol. 2015 Mar-Apr;33(2):140-6
pubmed: 25704934
Invest Ophthalmol Vis Sci. 2005 Feb;46(2):589-95
pubmed: 15671286
Ocul Surf. 2008 Jul;6(3):108-16
pubmed: 18781257
Jpn J Ophthalmol. 2016 Jan;60(1):1-6
pubmed: 26370944
Surv Ophthalmol. 2008 Jul-Aug;53(4):312-31
pubmed: 18572051
Cornea. 2000 May;19(3):307-12
pubmed: 10832689
Genome Res. 2008 Jul;18(7):1043-50
pubmed: 18502944
Nutrients. 2017 Oct 25;9(11):
pubmed: 29068389
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):128-136
pubmed: 28114568
Immunity. 2017 Jul 18;47(1):148-158.e5
pubmed: 28709803
Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1098-107
pubmed: 15912402

Auteurs

Francesco Petrillo (F)

Section of Ophthalmology, University Hospital "Policlinico-Vittorio Emanuele", 95123 Catania, Italy.

Danilo Pignataro (D)

Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli", 80138 Naples, Italy.

Maria Annunziata Lavano (MA)

Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli", 80138 Naples, Italy.

Biagio Santella (B)

Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli", 80138 Naples, Italy.

Veronica Folliero (V)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Carla Zannella (C)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Carlo Astarita (C)

Sbarro Institute for Cancer Research and Molecular Medicine, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA 19122, USA.

Caterina Gagliano (C)

Section of Ocular Immunology and Rare Diseases, University Hospital "Policlinico-Vittorio Emanuele", 95123 Catania, Italy.

Gianluigi Franci (G)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, 84081 Baronissi (S.A.), Italy.

Teresio Avitabile (T)

Section of Ophthalmology, University Hospital "Policlinico-Vittorio Emanuele", 95123 Catania, Italy.

Marilena Galdiero (M)

Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.

Classifications MeSH